BioNTech SE - ADR vs Danaos Corporation — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Danaos Corporation trades at $135.01 (market cap $2.46B). The key difference: BioNTech SE - ADR is far larger — about 9.5× Danaos Corporation's market cap, and Danaos Corporation pays a 2.67% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | DAC | |
|---|---|---|
Market Cap | $23.31B | $2.46B |
Sector | Health | Technology |
52-Week High | $119.34 | $143.15 |
52-Week Low | $83.89 | $84.05 |
Enterprise Value | $6.60B | $2.44B |
Dividend Yield | — | 2.67% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Danaos is a leading international owner of containerships, providing seaborne transportation services globally. It charters its fleet of vessels to major shipping lines across Asia, Europe, and the Americas.
Read more on DAC →